Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
about
COX-2 inhibitors: a CLASS act or Just VIGORously promotedClinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAITEULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Cardiovascular risk with non-steroidal anti-inflammatory drugs: clinical implicationsEfficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritisA combination of Scutellaria baicalensis and Acacia catechu extracts for short-term symptomatic relief of joint discomfort associated with osteoarthritis of the knee.Selective inhibitors of COX-2--are they safe for the stomach?Cost-effectiveness analyses of osteoarthritis oral therapies: a systematic review.Therapeutic potential of COX-2 inhibitors in arthritis.COX-2 inhibitors compared and contrasted.Celecoxib for osteoarthritis.Pathophysiology and first-line treatment of osteoarthritis.First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].The double-edged sword of COX-2 selective NSAIDsEfficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck disease (KBD) patientsKey questions concerning paracetamol and NSAIDs for osteoarthritis.Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxibParacetamol in osteoarthritis of the kneeLifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis.Developments in the treatment of juvenile arthritis.Differences between clinical trials and postmarketing use.Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis.Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trialsA Review on the Management of Hip and Knee Osteoarthritis.Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials.Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.Cardiovascular risks of cyclooxygenase inhibition.Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.Effects of intra-articular SHINBARO treatment on monosodium iodoacetate-induced osteoarthritis in rats.Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models.Efficacy of Elaeagnus Angustifolia extract in the treatment of knee osteoarthritis: a randomized controlled trial.Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors.
P2860
Q24529085-6A56D196-8D64-4FBF-B6A0-861E3B29A44FQ24602794-5895004B-8B02-4DEB-A205-1AB2869A8CC0Q24674132-C5D5A96B-3F71-4BE1-924D-75BD9F59C918Q27002539-57636244-F3EE-47F1-835C-DCD7510CA6F2Q28193800-05BDC76D-C432-4965-829B-019E82EC7A88Q32045021-356C1F97-1F06-41DA-990E-223CB452C2A7Q33556721-A1D4444E-85A0-4E2D-A909-71AFFE788354Q33680117-A4E0A3AC-DA53-494F-A5A9-AF943ABA2F3CQ33767965-BD3F3300-E19F-4807-AD99-2D37034EB7E1Q34122819-D729943A-0F3F-4554-9259-E6DBD8160CEAQ34384075-FFE2CE78-DFD2-4F0D-AAD2-3646CA0A66C1Q34481579-46A1A962-C73E-45B8-89EE-4231857752B9Q34515513-FFDA8FB0-F153-4A51-A269-27234ED09539Q34557021-E79645DB-A071-4DD2-9F40-C65E911724E7Q34579637-20EA9F17-BC00-4900-8B93-3354D4BFFD69Q34897041-4758506C-81BB-475D-BCD5-15D7F38232AFQ34994656-B1652F81-E09F-4EAD-BC43-13ECC00CB8D5Q35197713-94E0A8D7-8398-46C7-B5A2-F9051431E6E9Q35551913-1126C37A-C0B4-4A85-B4EE-F92F780416C4Q35553447-2E0825AC-F281-402B-BF54-28ABA3E77109Q35554393-A0CCA404-267A-4246-8404-576CC0D28343Q35576022-090B9018-F9F4-41FD-9FDC-9D99410A39C3Q35638355-70AF49EE-C50A-4FA4-A6A4-56D36883F995Q35642358-F02C77E1-6BD7-431E-B636-47FEA323FDECQ35814399-6A9F43CF-567A-402B-B92F-BBEF45EB3227Q35825899-5DD561B2-F95E-43D0-9FCD-2E90D18232A8Q35925230-6E9682AD-F24C-4E94-AB0D-DCEFEE00A24FQ35961855-4F5F4AB0-8220-4130-9B6A-EDD111518141Q36112637-CFE0178C-2801-47A6-BEC4-825A0C35A40BQ36195392-4A7A817B-90EF-484B-8DF5-DD973D1E4AD5Q36471998-EB94DE42-BA48-4296-961C-11E650A0598CQ36475626-0E3CB58D-929E-4310-BDC4-50F61935F279Q36486905-3B2D5366-AC91-42C3-982C-31EC277D2B6FQ36520638-195A824C-CC2C-400C-B302-29ADB0B1AFEBQ36600338-0306E077-AE4E-4638-A7EF-EE49310E502EQ36785746-54A27F2C-A1FF-4C81-9182-C2B1AF3F3549Q36894945-7C33C843-932A-4F21-BE35-968654BB14C7Q36936823-D06F59B1-4B3A-43CC-BB36-98E8ED5D97FDQ37006361-25D98923-8E32-439D-A30E-C1413DA9DB50Q37061561-10111819-4354-4F4A-B7A7-5B7DC3A30321
P2860
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Treatment of osteoarthritis wi ...... a randomized controlled trial.
@en
Treatment of osteoarthritis wi ...... a randomized controlled trial.
@nl
type
label
Treatment of osteoarthritis wi ...... a randomized controlled trial.
@en
Treatment of osteoarthritis wi ...... a randomized controlled trial.
@nl
prefLabel
Treatment of osteoarthritis wi ...... a randomized controlled trial.
@en
Treatment of osteoarthritis wi ...... a randomized controlled trial.
@nl
P2093
P356
P1476
Treatment of osteoarthritis wi ...... a randomized controlled trial.
@en
P2093
J I McMillen
J J Fiechtner
K M Verburg
P C Isakson
R C Hubbard
W G Bensen
P304
P356
10.4065/74.11.1095
P407
P577
1999-11-01T00:00:00Z